The Latest Breaking News from FDA

FDA expert committee needs more data to decide when to give out COVID boosters — and who needs them most

The head of the Food and Drug Administration has announced an overhaul of the agency's food safety and nutrition division

Neuroscientist Thomas Oxley thinks Synchron’s brain implant, which is essentially a stent placed at the base of the motor cortex, is the Goldilocks of brain-computer interfaces. Here's how it works.

PHILADELPHIA -- The Food and Drug Administration urged food manufacturers last week to significantly reduce the amount of lead in processed baby food.

This month, the Food and Drug Administration approved a new drug, lecanemab, for the treatment of Alzheimer’s disease. The drug, sold under the brand name Leqembi, was developed by Japanese pharmaceutical company Eisai and will be marketed commercially in partnership with American pharmaceutical company Biogen. Biogen, notably, is the maker…

The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.

In recent months, patients have reported problems filling nearly every type of ADHD medication prescription – and no one seems to know why

The Food and Drug Administration has withdrawn its provisional support for the use of Evusheld, a medication that was once a valuable tool for preventing patients with weakened immune systems from becoming severely ill with COVID-19.

The FDA announced a draft of new guidelines Friday that would end mandatory three-month abstinence periods for men who have sex with men. For Illinois hospitals and blood banks, the change is long overdue.

The Food and Drug Administration announced Friday a proposal to ease restrictions on blood donation by gay and bisexual men. The move was celebrated by LGBTQ rights advocates as “a tremendous leap forward toward elevating science over stigma.”

An FDA advisory committee recommended a major overhaul to how COVID shots are issued